What is Syndax Pharmaceuticals's revenue?

Syndax Pharmaceuticals (SNDX) reported revenue of $64.86M in Q1 2026.

How has Syndax Pharmaceuticals's revenue changed year-over-year?

Syndax Pharmaceuticals's revenue increased by 223.6% year-over-year, from $20.04M to $64.86M.

What is the long-term trend for Syndax Pharmaceuticals's revenue?

Over 4 years (2021 to 2025), Syndax Pharmaceuticals's revenue has grown at a 5.4% compound annual growth rate (CAGR), from $139.71M to $172.6M.

Syndax Pharmaceuticals SNDX Revenue

Revenue at other companies

HTF

Heartflow, Inc. Common StockHTFL

$52.59M+41.3%

Cal-Maine FoodsCALM

$666.95M-53.0%

DJT

Trump Media & Technology GroupDJT

$871.2K+6.1%

ADMA BiologicsADMA

$114.49M-0.3%

Minerals TechnologiesMTX

$546.9M+11.2%

Lincoln Educational Services CorporationLINC

$143.96M+22.5%

Other financials

Income statement

See full

Revenue$64.9M+224%

Operating income-$34.2M+59.2%

Net income-$42.7M+49.7%

EPS (diluted)-$0.48+51.0%

Balance sheet

See full

Cash & equivalents$130.9M-15.0%

Total debt$350.5M+4.2%

Total equity$41.6M-80.6%

Total assets$472.7M-26.2%

Cash flow

See full

Operating cash flow-$50.3M+47.1%

CapEx$46.8K—

Free cash flow-$80.8M-17.6%

Valuation

See full

Market cap$1.77B+95.0%

Profitability

See full

Operating margin-102.8%-47.8pp

Net margin-111.9%-51.5pp

FCF margin-187.2%-85.4pp

Returns & leverage

See full

Return on equity-189.5%-8,509pp

Debt / equity8.4×+6.9×

Current ratio5.5×-0.3×

Where this comes from

Reported directly by Syndax Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Syndax Pharmaceuticals's revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Syndax Pharmaceuticals's revenue?: Syndax Pharmaceuticals (SNDX) reported revenue of $64.86M in Q1 2026.
How has Syndax Pharmaceuticals's revenue changed year-over-year?: Syndax Pharmaceuticals's revenue increased by 223.6% year-over-year, from $20.04M to $64.86M.
What is the long-term trend for Syndax Pharmaceuticals's revenue?: Over 4 years (2021 to 2025), Syndax Pharmaceuticals's revenue has grown at a 5.4% compound annual growth rate (CAGR), from $139.71M to $172.6M.